Forbion is Europe's leading biotech investment company, with an outstanding track record and exceptional technical expertise, particularly in drug development. Forbion BioEconomy is their first fund dedicated to biomaterials and agriculture. It focuses on high-impact start-ups that have demonstrated the feasibility of their product, and supports them through to profitability.
With Forbion, we are joining forces with one of the world's leading biotech investors. This science is starting to find extraordinary industrial (biomaterials), environmental and agricultural outlets. Thanks to Forbion's new fund dedicated to these fast-emerging fields, we'll have a valuable window on innovation in life sciences.
